VANCOMYCIN HYDROCHLORIDE 1.5 g/300mL (Vancomycin Hydrochloride INJECTION, SOLUTION) 1.5 g/300mL

VANCOMYCIN HYDROCHLORIDE 1.5 g/300mL is an injectable solution used for specific medical treatments. This antibiotic solution is designed for intravitreal administration and is manufactured by Baxter Healthcare Corporation.

Strength

1.5 g/300mL

Pack Size

300 mL in 1 BAG (0338-0124-04)

Manufacturer / TM Owner

Baxter Healthcare Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VANCOMYCIN HYDROCHLORIDE is primarily used for its antibiotic properties. It is often administered intravitreally to address certain ocular infections. This solution is intended for use in controlled medical settings to manage conditions that require targeted antibiotic treatment.

Side Effects

When administered as directed, VANCOMYCIN HYDROCHLORIDE may help reduce bacterial activity in the eye. Patients should be monitored for any adverse reactions, as with any medical treatment.

Precautions & Warnings

VANCOMYCIN HYDROCHLORIDE should be handled with care, following proper sterile techniques. It is crucial to store and administer this solution under the guidance of a healthcare professional to ensure safety and efficacy.

Avoid Interactions

VANCOMYCIN HYDROCHLORIDE may interact with other medications, particularly other antibiotics or medications that affect the eyes. Patients should inform their healthcare provider about all current medications to avoid potential interactions.

Frequently Asked Questions

VANCOMYCIN HYDROCHLORIDE is used as an antibiotic solution, often administered intravitreally to treat certain ocular infections.

VANCOMYCIN HYDROCHLORIDE is designed for intravitreal administration and should be handled by a healthcare professional in a controlled medical setting.

VANCOMYCIN HYDROCHLORIDE may help reduce bacterial activity in the eye when administered as directed.

VANCOMYCIN HYDROCHLORIDE should be handled with care, following proper sterile techniques, and administered under the guidance of a healthcare professional.

VANCOMYCIN HYDROCHLORIDE may interact with other antibiotics or medications that affect the eyes, so patients should inform their healthcare provider about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.